1. Home
  2. SSKN vs BFRI Comparison

SSKN vs BFRI Comparison

Compare SSKN & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Strata Skin Sciences Inc.

SSKN

Strata Skin Sciences Inc.

HOLD

Current Price

$1.23

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$0.95

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SSKN
BFRI
Founded
1989
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
8.4M
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
SSKN
BFRI
Price
$1.23
$0.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$6.00
$2.75
AVG Volume (30 Days)
96.3K
433.8K
Earning Date
11-13-2025
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$30,980,000.00
$37,164,000.00
Revenue This Year
N/A
$11.37
Revenue Next Year
$7.74
$10.96
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.11
52 Week Low
$1.18
$0.54
52 Week High
$3.86
$1.24

Technical Indicators

Market Signals
Indicator
SSKN
BFRI
Relative Strength Index (RSI) 39.60 64.03
Support Level $1.18 $0.80
Resistance Level $1.32 $1.01
Average True Range (ATR) 0.05 0.06
MACD -0.00 0.02
Stochastic Oscillator 3.12 81.08

Price Performance

Historical Comparison
SSKN
BFRI

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Share on Social Networks: